CIT GAP Funds invests in e-Kare

The Center for Innovative Technology (CIT) announced today that its CIT GAP Funds has invested in e-Kare Inc. of Fairfax, a digital health company that greatly speeds the assessment and monitoring of chronic wounds.

Chronic wounds include pressure, venous, and diabetic ulcers, severe burn, and complex surgical wounds that affect over 6.5 million U.S. patients, costing over $25 billion.  Founded in 2013 as a spin-off enterprise from the Children’s National Medical Center (CNMC), e-Karehas developed a proprietary point-of-care subscription service that enables comprehensive 3-dimensional wound assessment on a mobile device.  It also provides a HIPAA-compliant cloud management platform to support the front-end device, allowing clinicians to easily archive, access and analyze the clinical images and informatics generated from the e-Kare sensor.  The management platform can also interface with the clinicians’ existing electronic health record to further streamline care delivery.

Pete Jobse, President and CEO of CIT, said, “Healthcare reform is driving innovation, and companies like e-Kare are providing innovative solutions to improve service delivery and lower costs. We are always excited to find and invest in teams and companies like e-Kare.”